Critical · 1 mfr
9
High · 2 mfrs
17
Moderate · 3 mfrs
11
Lower · 4+ mfrs
32
Critical: 9 (13%)High: 17 (25%)Moderate: 11 (16%)Lower: 32 (46%)
Showing 69 of 69 drugs
Source: openFDA Drug Shortages API · Last refreshed 02:36 AM · 1,604 records
| Risk tier | ||||||
|---|---|---|---|---|---|---|
Riluzole Oral Suspension Oral Suspension | 1 | Not specified; Requirements related to complying with good manufacturing practices | Neurology | 1,008 | Current | Critical |
Methylphenidate Film, Extended Release Film, Extended Release | 1 | Not specified | Psychiatry | 609 | Current | Critical |
Bacitracin Ophthalmic Ointment Ophthalmic Ointment | 1 | Discontinuation of the manufacture of the drug | Anti-InfectiveOphthalmology | 606 | Current | Critical |
Pentostatin Injection Injection | 1 | Other | Oncology | 64 | Current | Critical |
Echothiophate Iodide Ophthalmic Solution Ophthalmic Solution | 1 | Other | Ophthalmology | 2,593 | Current | Critical |
Conivaptan Hydrochloride Injection Injection | 1 | Delay in shipping of the drug | Cardiovascular | 1,691 | Current | Critical |
Furosemide Oral Solution Oral Solution | 1 | Not specified | Cardiovascular | 213 | Current | Critical |
Isocarboxazid Tablet Tablet | 1 | Other | Psychiatry | 197 | Current | Critical |
Triamcinolone Hexacetonide Injection Injection | 1 | Not specified | Rheumatology | 2,005 | Current | Critical |
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Injection | 2 | Not specified; Other; Demand increase for the drug | AnesthesiaPediatric | 5,364 | Current | High |
Meperidine Hydrochloride Injection Injection | 2 | Not specified | Analgesia/Addiction | 518 | Current | High |
Dextrose Monohydrate 50% Injection Injection | 2 | Other; Demand increase for the drug | Endocrinology/MetabolismGastroenterologyPediatric | 1,751 | Current | High |
Technetium TC-99M Pyrophosphate Kit Injection Injection | 2 | Other; Shortage of an active ingredient | Medical Imaging | 1,038 | Current | High |
Quinapril/Hydrochlorothiazide Tablet Tablet | 2 | Discontinuation of the manufacture of the drug; Not specified | Cardiovascular | 1,380 | Current | High |
Streptozocin Powder, For Solution Powder, For Solution | 2 | Not specified; Other | Oncology | 1,571 | Current | High |
Sufentanil Citrate Injection Injection | 2 | Other | Analgesia/AddictionPediatric | 1,641 | Current | High |
Promethazine Hydrochloride Injection Injection | 2 | Not specified; Demand increase for the drug; Other | Analgesia/AddictionGastroenterologyPediatric | 1,074 | Current | High |
Hydroxocobalamin Injection Injection | 2 | Other | Other | 725 | Current | High |
Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Injection | 2 | Not specified; Demand increase for the drug; Other; Delay in shipping of the drug | Anesthesia | 3,174 | Current | High |
Penicillin G Benzathine Injection Injection | 2 | Other; Not specified | Anti-Infective | 1,283 | Current | High |
Propranolol Hydrochloride Injection Injection | 2 | Delay in shipping of the drug; Shortage of an active ingredient | Cardiovascular | 1,095 | Current | High |
Cefotaxime Sodium Powder, for Solution Powder, For Solution | 2 | Demand increase for the drug; Not specified | Anti-InfectivePediatric | 4,273 | Current | High |
Flurazepam Hydrochloride Capsule Capsule | 2 | Not specified; Regulatory delay | OncologyOtherNeurology | 1,549 | Current | High |
Rifampin Capsule Capsule | 2 | Not specified; Discontinuation of the manufacture of the drug | Anti-Infective | 1,773 | Current | High |
Desmopressin Acetate Spray Spray | 2 | Requirements related to complying with good manufacturing practices; Delay in shipping of the drug | Hematology | 2,058 | Current | High |
Valproate Sodium Injection Injection | 2 | Not specified; Demand increase for the drug | Neurology | 2,130 | Current | High |
Remifentanil Hydrochloride Injection Injection | 3 | Not specified; Demand increase for the drug; Delay in shipping of the drug | Analgesia/Addiction | 1,585 | Current | Moderate |
Lisdexamfetamine Dimesylate Tablet, Chewable Tablet, Chewable | 3 | Not specified | Psychiatry | 1,204 | Current | Moderate |
Fentanyl Citrate Injection Injection | 3 | Not specified; Demand increase for the drug; Other | Analgesia/AddictionPediatric | 5,416 | Current | Moderate |
Dobutamine Hydrochloride Injection Injection | 3 | Not specified; Other | CardiovascularPediatricRenal | 3,280 | Current | Moderate |
Liraglutide Injection Injection | 3 | Delay in shipping of the drug; Discontinuation of the manufacture of the drug; Not specified | Endocrinology/Metabolism | 1,200 | Current | Moderate |
Dopamine Hydrochloride Injection Injection | 3 | Other; Not specified; Demand increase for the drug | Cardiovascular | 3,280 | Current | Moderate |
Amino Acid Injection Injection | 3 | Not specified; Shortage of an active ingredient; Shortage of an inactive ingredient component | Gastroenterology | 2,152 | Current | Moderate |
Dextrose Monohydrate 70% Injection Injection | 3 | Not specified | Endocrinology/MetabolismGastroenterologyOther | 749 | Current | Moderate |
Rifampin Injection Injection | 3 | Other; Discontinuation of the manufacture of the drug; Demand increase for the drug | Anti-Infective | 2,081 | Current | Moderate |
Sterile Water Irrigant Irrigant | 3 | Discontinuation of the manufacture of the drug; Not specified; Other | GastroenterologyOtherPediatric | 1,281 | Current | Moderate |
Metronidazole Injection Injection | 3 | Not specified; Other; Discontinuation of the manufacture of the drug | Anti-Infective | 1,751 | Current | Moderate |
Dextrose Monohydrate 5% Injection Injection | 4 | Not specified; Demand increase for the drug | Endocrinology/MetabolismGastroenterologyOther | 1,719 | Current | Lower |
Lorazepam Injection Injection | 4 | Other; Demand increase for the drug; Not specified | Neurology | 3,102 | Current | Lower |
Ifosfamide Injection Injection | 4 | Not specified; Demand increase for the drug; Requirements related to complying with good manufacturing practices | OncologyPediatric | 140 | Current | Lower |
Hydromorphone Hydrochloride Injection Injection | 4 | Other; Not specified; Demand increase for the drug | Analgesia/Addiction | 3,286 | Current | Lower |
Clindamycin Phosphate Injection Injection | 4 | Not specified; Other; Discontinuation of the manufacture of the drug | Anti-Infective | 1,319 | Current | Lower |
Quinapril Hydrochloride Tablet Tablet | 4 | Shortage of an active ingredient; Discontinuation of the manufacture of the drug; Not specified; Requirements related to complying with good manufacturing practices | Cardiovascular | 1,380 | Current | Lower |
Dextrose Monohydrate 10% Injection Injection | 4 | Not specified; Discontinuation of the manufacture of the drug | Endocrinology/MetabolismGastroenterologyOther | 1,704 | Current | Lower |
Cromolyn Sodium Concentrate Concentrate | 4 | Other; Not specified | Pulmonary/Allergy | 1,092 | Current | Lower |
Heparin Sodium Injection Injection | 4 | Not specified; Other; Demand increase for the drug | Hematology | 3,272 | Current | Lower |
Sodium Bicarbonate Injection Injection | 5 | Not specified; Other; Demand increase for the drug | Endocrinology/MetabolismGastroenterologyPediatric | 3,530 | Current | Lower |
Morphine Sulfate Injection Injection | 5 | Not specified; Other; Demand increase for the drug; Discontinuation of the manufacture of the drug | Analgesia/Addiction | 3,286 | Current | Lower |
Ropivacaine Hydrochloride Injection Injection | 5 | Not specified; Demand increase for the drug; Other; Delay in shipping of the drug | Anesthesia | 3,143 | Current | Lower |
Sterile Water Injection Injection | 5 | Not specified; Demand increase for the drug; Other | Other | 1,802 | Current | Lower |
Methotrexate Sodium Injection Injection | 5 | Demand increase for the drug; Not specified; Other | RheumatologyOncology | 1,327 | Current | Lower |
Sodium Acetate Injection Injection | 5 | Not specified; Other | Total Parenteral NutritionEndocrinology/MetabolismGastroenterology | 3,922 | Current | Lower |
Methylprednisolone Acetate Injection Injection | 5 | Not specified; Demand increase for the drug; Shortage of an active ingredient; Other | Rheumatology | 1,597 | Current | Lower |
Dexamethasone Sodium Phosphate Injection Injection | 5 | Not specified; Demand increase for the drug | DermatologyEndocrinology/MetabolismGastroenterology | 2,821 | Current | Lower |
Methylphenidate Hydrochloride Tablet, Extended Release Tablet | 6 | Demand increase for the drug; Not specified; Other; Discontinuation of the manufacture of the drug | Psychiatry | 1,192 | Current | Lower |
Midazolam Hydrochloride Injection Injection | 6 | Demand increase for the drug; Delay in shipping of the drug; Other; Not specified | AnesthesiaNeurology | 2,402 | Current | Lower |
Etomidate Injection Injection | 6 | Not specified; Other; Demand increase for the drug | Anesthesia | 1,486 | Current | Lower |
Clonazepam Tablet Tablet | 6 | Not specified; Other | NeurologyPediatricPsychiatry | 1,330 | Current | Lower |
Ketorolac Tromethamine Injection Injection | 7 | Not specified; Demand increase for the drug; Delay in shipping of the drug; Other | Analgesia/Addiction | 3,143 | Current | Lower |
Furosemide Injection Injection | 8 | Other; Not specified; Discontinuation of the manufacture of the drug; Requirements related to complying with good manufacturing practices; Demand increase for the drug | Cardiovascular | 2,397 | Current | Lower |
Bupivacaine Hydrochloride Injection Injection | 8 | Not specified; Discontinuation of the manufacture of the drug; Other; Delay in shipping of the drug; Demand increase for the drug | AnesthesiaAnalgesia/Addiction | 3,174 | Current | Lower |
Atropine Sulfate Injection Injection | 8 | Other; Not specified; Discontinuation of the manufacture of the drug; Requirements related to complying with good manufacturing practices | AnesthesiaNeurologyPediatric | 5,416 | Current | Lower |
Carboplatin Injection Injection | 8 | Other; Demand increase for the drug; Not specified; Discontinuation of the manufacture of the drug; Delay in shipping of the drug | Oncology | 1,281 | Current | Lower |
Azacitidine Injection Injection | 9 | Other; Discontinuation of the manufacture of the drug; Not specified; Demand increase for the drug | Oncology | 2,142 | Current | Lower |
Lidocaine Hydrochloride Injection Injection | 10 | Not specified; Demand increase for the drug; Other | AnesthesiaPediatricCardiovascular | 3,174 | Current | Lower |
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Tablet | 11 | Demand increase for the drug; Not specified; Shortage of an active ingredient; Other | Psychiatry | 1,172 | Current | Lower |
Rocuronium Bromide Injection Injection | 11 | Not specified; Delay in shipping of the drug; Demand increase for the drug | Anesthesia | 1,353 | Current | Lower |
Lisdexamfetamine Dimesylate Capsule Capsule | 13 | Not specified; Shortage of an active ingredient; Other | Psychiatry | 1,023 | Current | Lower |
Dexmedetomidine Hydrochloride Injection Injection | 16 | Not specified; Delay in shipping of the drug; Discontinuation of the manufacture of the drug; Other; Demand increase for the drug | Anesthesia | 2,394 | Current | Lower |